Filed: 11/14/2022ACC: 0001172661-22-002573
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 40 equity positions with a total reported market value of $415.3K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
40
Positions
$415.3K
Total AUM (reported)
40.28M
Total Shares
Allocation by class
COM$352.6K84.9%
SHS USD$28.7K6.9%
SPON ADR$13.1K3.1%
SHS$11.3K2.7%
ADS$4.4K1.1%
CLASS A ORD$3.8K0.9%
SPONSORED ADS$1.4K0.3%
Portfolio Concentration
Top 3$86.9K20.9%
4–10$151.3K36.4%
11–25$139.7K33.6%
Rest$37.4K9.0%
Top 3 weight
20.9%
Top 10 weight
57.4%
Voting Authority Distribution
Total shares with voting rights: 40.28M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
40.28M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other40
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings40
Rows:
XENON PHARMACEUTICALS INC
DFNDShares850K
TypeSH
Market value$30.7K
7.39%
Sole
0.00
Shared
850K
None
0.00
JAZZ PHARMACEUTICALS PLC
DFNDShares215K
TypeSH
Market value$28.7K
6.90%
Sole
0.00
Shared
215K
None
0.00
POINT BIOPHARMA GLOBAL INC
DFNDShares3.56M
TypeSH
Market value$27.5K
6.63%
Sole
0.00
Shared
3.56M
None
0.00
ALPINE IMMUNE SCIENCES INC
DFNDShares3.45M
TypeSH
Market value$24.8K
5.98%
Sole
0.00
Shared
3.45M
None
0.00
TRAVERE THERAPEUTICS INC
DFNDShares966.11K
TypeSH
Market value$23.8K
5.73%
Sole
0.00
Shared
966.11K
None
0.00
HERON THERAPEUTICS INC
DFNDShares5.65M
TypeSH
Market value$23.5K
5.65%
Sole
0.00
Shared
5.65M
None
0.00
KALVISTA PHARMACEUTICALS INC
DFNDShares1.55M
TypeSH
Market value$22.5K
5.42%
Sole
0.00
Shared
1.55M
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares1.04M
TypeSH
Market value$21.8K
5.24%
Sole
0.00
Shared
1.04M
None
0.00
RELMADA THERAPEUTICS INC
DFNDShares510K
TypeSH
Market value$18.9K
4.55%
Sole
0.00
Shared
510K
None
0.00
ACLARIS THERAPEUTICS INC
DFNDShares1.02M
TypeSH
Market value$16.0K
3.86%
Sole
0.00
Shared
1.02M
None
0.00
VAXCYTE INC
DFNDShares600K
TypeSH
Market value$14.4K
3.47%
Sole
0.00
Shared
600K
None
0.00
GALAPAGOS NV
DFNDShares306.41K
TypeSH
Market value$13.1K
3.15%
Sole
0.00
Shared
306.41K
None
0.00
ACUMEN PHARMACEUTICALS INC
DFNDShares1.20M
TypeSH
Market value$12.0K
2.90%
Sole
0.00
Shared
1.20M
None
0.00
ALKERMES PLC
DFNDShares507.50K
TypeSH
Market value$11.3K
2.73%
Sole
0.00
Shared
507.50K
None
0.00
SEAGEN INC
DFNDShares76.50K
TypeSH
Market value$10.5K
2.52%
Sole
0.00
Shared
76.50K
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.05M
TypeSH
Market value$10.4K
2.51%
Sole
0.00
Shared
1.05M
None
0.00
CINCOR PHARMA INC
DFNDShares301.32K
TypeSH
Market value$9.9K
2.38%
Sole
0.00
Shared
301.32K
None
0.00
VENTYX BIOSCIENCES INC
DFNDShares269.97K
TypeSH
Market value$9.4K
2.27%
Sole
0.00
Shared
269.97K
None
0.00
TRICIDA INC
DFNDShares870K
TypeSH
Market value$9.1K
2.20%
Sole
0.00
Shared
870K
None
0.00
RAPT THERAPEUTICS INC
DFNDShares315K
TypeSH
Market value$7.6K
1.82%
Sole
0.00
Shared
315K
None
0.00
UROGEN PHARMA LTD
DFNDShares873.42K
TypeSH
Market value$7.3K
1.75%
Sole
0.00
Shared
873.42K
None
0.00
REPLIMUNE GROUP INC
DFNDShares390K
TypeSH
Market value$6.7K
1.62%
Sole
0.00
Shared
390K
None
0.00
MADRIGAL PHARMACEUTICALS INC
DFNDShares95.50K
TypeSH
Market value$6.2K
1.49%
Sole
0.00
Shared
95.50K
None
0.00
MILESTONE PHARMACEUTICALS IN
DFNDShares674.66K
TypeSH
Market value$6.2K
1.49%
Sole
0.00
Shared
674.66K
None
0.00
89BIO INC
DFNDShares955K
TypeSH
Market value$5.5K
1.33%
Sole
0.00
Shared
955K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XENON PHARMACEUTICALS INCDFND | COM | 850K | SH | $30.7K 7.39% | 0.00 | 850K | 0.00 |
JAZZ PHARMACEUTICALS PLCDFND | SHS USD | 215K | SH | $28.7K 6.90% | 0.00 | 215K | 0.00 |
POINT BIOPHARMA GLOBAL INCDFND | COM | 3.56M | SH | $27.5K 6.63% | 0.00 | 3.56M | 0.00 |
ALPINE IMMUNE SCIENCES INCDFND | COM | 3.45M | SH | $24.8K 5.98% | 0.00 | 3.45M | 0.00 |
TRAVERE THERAPEUTICS INCDFND | COM | 966.11K | SH | $23.8K 5.73% | 0.00 | 966.11K | 0.00 |
HERON THERAPEUTICS INCDFND | COM | 5.65M | SH | $23.5K 5.65% | 0.00 | 5.65M | 0.00 |
KALVISTA PHARMACEUTICALS INCDFND | COM | 1.55M | SH | $22.5K 5.42% | 0.00 | 1.55M | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 1.04M | SH | $21.8K 5.24% | 0.00 | 1.04M | 0.00 |
RELMADA THERAPEUTICS INCDFND | COM | 510K | SH | $18.9K 4.55% | 0.00 | 510K | 0.00 |
ACLARIS THERAPEUTICS INCDFND | COM | 1.02M | SH | $16.0K 3.86% | 0.00 | 1.02M | 0.00 |
VAXCYTE INCDFND | COM | 600K | SH | $14.4K 3.47% | 0.00 | 600K | 0.00 |
GALAPAGOS NVDFND | SPON ADR | 306.41K | SH | $13.1K 3.15% | 0.00 | 306.41K | 0.00 |
ACUMEN PHARMACEUTICALS INCDFND | COM | 1.20M | SH | $12.0K 2.90% | 0.00 | 1.20M | 0.00 |
ALKERMES PLCDFND | SHS | 507.50K | SH | $11.3K 2.73% | 0.00 | 507.50K | 0.00 |
SEAGEN INCDFND | COM | 76.50K | SH | $10.5K 2.52% | 0.00 | 76.50K | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.05M | SH | $10.4K 2.51% | 0.00 | 1.05M | 0.00 |
CINCOR PHARMA INCDFND | COM | 301.32K | SH | $9.9K 2.38% | 0.00 | 301.32K | 0.00 |
VENTYX BIOSCIENCES INCDFND | COM | 269.97K | SH | $9.4K 2.27% | 0.00 | 269.97K | 0.00 |
TRICIDA INCDFND | COM | 870K | SH | $9.1K 2.20% | 0.00 | 870K | 0.00 |
RAPT THERAPEUTICS INCDFND | COM | 315K | SH | $7.6K 1.82% | 0.00 | 315K | 0.00 |
UROGEN PHARMA LTDDFND | COM | 873.42K | SH | $7.3K 1.75% | 0.00 | 873.42K | 0.00 |
REPLIMUNE GROUP INCDFND | COM | 390K | SH | $6.7K 1.62% | 0.00 | 390K | 0.00 |
MADRIGAL PHARMACEUTICALS INCDFND | COM | 95.50K | SH | $6.2K 1.49% | 0.00 | 95.50K | 0.00 |
MILESTONE PHARMACEUTICALS INDFND | COM | 674.66K | SH | $6.2K 1.49% | 0.00 | 674.66K | 0.00 |
89BIO INCDFND | COM | 955K | SH | $5.5K 1.33% | 0.00 | 955K | 0.00 |
Page 1 of 2